Effects of lipid-lowering therapy with fibrates on endothelial function in patients with type 2 diabetes mellitus

被引：0
|
作者：
Watanabe, H
Nakagawa, K
Kakihana, M
机构：
[1] Ibaraki Prefectural Univ Hlth Sci, Ami, Ibaraki, Japan
[2] KINU Med Assoc Hosp, Mitsukaido, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2002年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：210A / 210A
页数：1
相关论文
共 50 条
  • [1] Effects of lipid-lowering therapy with bezafibrate on endothelial function and aortic stiffness in patients with type 2 diabetes mellitus
    Watanabe, H
    Kakihana, M
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 : 419 - 419
  • [2] Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus
    Betteridge, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 10S - 15S
  • [3] Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapy
    Fegan, PG
    Shore, AC
    Mawson, D
    Tooke, JE
    MacLeod, KM
    [J]. DIABETIC MEDICINE, 2005, 22 (12) : 1670 - 1676
  • [4] Lipid-lowering therapy in diabetes mellitus
    Niemeijer-Kanters, SDJM
    Banga, JD
    Erkelens, DW
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2001, 58 (05): : 214 - 222
  • [5] Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus
    Okada, Kenta
    Yagyu, Hiroaki
    Kotani, Kazuhiko
    Miyamoto, Michiaki
    Osuga, Jun-ichi
    Nagasaka, Shoichiro
    Ishibashi, Shun
    [J]. ENDOCRINE JOURNAL, 2010, 57 (10) : 903 - 908
  • [6] Determinants of inertia with lipid-lowering treatment in patients with type 2 diabetes mellitus
    Garcia Diaz, Eduardo
    Ramirez Medina, Davinia
    Morera Porras, Oscar Mauricio
    Cabrera Mateos, Jose Luis
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (04): : 223 - 231
  • [7] Lipid-lowering therapy in people with type 2 diabetes
    Colagiuri, S
    Best, J
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 617 - 623
  • [8] Pioglitazone improves diabetic dyslipidaemia in patients with type 2 diabetes mellitus with or without lipid-lowering therapy
    Schöfl, C
    Luebben, G
    [J]. CLINICAL DRUG INVESTIGATION, 2005, 25 (05) : 341 - 345
  • [9] Pioglitazone improves diabetic dyslipidaemia in patients with type 2 diabetes mellitus with or without lipid-lowering therapy
    Schöfl C.
    Luebben G.
    [J]. Clinical Drug Investigation, 2005, 25 (5) : 341 - 345
  • [10] Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention
    Steinmetz, Armin
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (04) : 286 - 293
12345